ID29970A - Metode untuk mengobati penyakit neovaskuler okuler - Google Patents

Metode untuk mengobati penyakit neovaskuler okuler

Info

Publication number
ID29970A
ID29970A IDW00200101090A ID20011090A ID29970A ID 29970 A ID29970 A ID 29970A ID W00200101090 A IDW00200101090 A ID W00200101090A ID 20011090 A ID20011090 A ID 20011090A ID 29970 A ID29970 A ID 29970A
Authority
ID
Indonesia
Prior art keywords
treating
oulner
methods
neovascular disease
neovascular
Prior art date
Application number
IDW00200101090A
Other languages
English (en)
Inventor
Romulus Kimbro Brazzell
Jeanette Marjorie Wood
Peter Anthony Campochiaro
Frances Elizabeth Kane
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ID29970A publication Critical patent/ID29970A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW00200101090A 1998-11-23 1999-11-22 Metode untuk mengobati penyakit neovaskuler okuler ID29970A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19867798A 1998-11-23 1998-11-23

Publications (1)

Publication Number Publication Date
ID29970A true ID29970A (id) 2001-10-25

Family

ID=22734344

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101090A ID29970A (id) 1998-11-23 1999-11-22 Metode untuk mengobati penyakit neovaskuler okuler

Country Status (19)

Country Link
EP (1) EP1131073B1 (id)
JP (2) JP2002530342A (id)
KR (1) KR100698449B1 (id)
CN (1) CN1172673C (id)
AT (1) ATE252387T1 (id)
AU (1) AU761092B2 (id)
BR (1) BR9915569A (id)
CA (1) CA2348890C (id)
DE (1) DE69912304T2 (id)
DK (1) DK1131073T3 (id)
ES (1) ES2211197T3 (id)
HK (1) HK1040182A1 (id)
ID (1) ID29970A (id)
IL (2) IL142757A0 (id)
NO (1) NO328085B1 (id)
NZ (1) NZ511559A (id)
PT (1) PT1131073E (id)
WO (1) WO2000030651A1 (id)
ZA (1) ZA200103925B (id)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0122318D0 (en) * 2001-09-14 2001-11-07 Novartis Ag Organic compounds
US20030119812A1 (en) * 2001-11-08 2003-06-26 Brazzell Romulus Kimbro Method for decreasing capillary permeability in the retina
CN101897662B (zh) * 2002-07-23 2013-05-22 诺瓦提斯公司 包含药物、软膏基质和增溶剂/分散剂的眼用软膏剂组合物
MX2007001155A (es) * 2004-07-29 2007-08-14 Creabilis Therapeutics Spa Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1.
CN101580515B (zh) * 2008-05-16 2011-06-08 上海医药工业研究院 一种星形孢菌素提取纯化的方法
US8614221B2 (en) 2009-03-11 2013-12-24 Merck Sharp & Dohme Corp. Inhibitors of Akt activity
WO2010114780A1 (en) 2009-04-01 2010-10-07 Merck Sharp & Dohme Corp. Inhibitors of akt activity
CN102924479A (zh) * 2011-08-09 2013-02-13 山东鲁北药业有限公司 一种星孢菌素类衍生物的半合成方法
EP2755482B1 (en) 2011-09-15 2016-06-01 Merck Sharp & Dohme Corp. Combination of mk-1775 and mk-8776 for treating cancer
JP6290237B2 (ja) 2012-11-28 2018-03-07 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． 癌を処置するための組成物および方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL86632A0 (en) * 1987-06-15 1988-11-30 Ciba Geigy Ag Derivatives substituted at methyl-amino nitrogen
US5093330A (en) * 1987-06-15 1992-03-03 Ciba-Geigy Corporation Staurosporine derivatives substituted at methylamino nitrogen
EP0651650A4 (en) * 1992-07-08 1996-04-17 Celtrix Pharma METHOD FOR TREATING EYE DISEASES BY MEANS OF TGF - g (b).
US6410322B1 (en) * 1993-07-27 2002-06-25 Hybridon Inc Antisense oligonucleotide inhibition of vascular endothelial growth factor expression
AU2066797A (en) * 1996-03-21 1997-10-10 Sugen, Inc. Assays for kdr/flk-1 receptor tyrosine kinase inhibitors
UA54427C2 (uk) * 1996-05-01 2003-03-17 Елі Ліллі Енд Компані Спосіб лікування очних захворювань, які пов'язані з фактором васкулярного ендотеліального росту
JP2002506028A (ja) * 1998-03-13 2002-02-26 ジョンズ ホプキンズ ユニヴァーシティ スクール オヴ メディシン 糖尿病性網膜症または眼炎症の処置におけるゲニステインのようなタンパク質チロシンインヒビターの使用

Also Published As

Publication number Publication date
BR9915569A (pt) 2001-08-14
KR20010078398A (ko) 2001-08-20
JP2011088938A (ja) 2011-05-06
NZ511559A (en) 2004-01-30
ATE252387T1 (de) 2003-11-15
JP2002530342A (ja) 2002-09-17
NO20012490L (no) 2001-06-25
KR100698449B1 (ko) 2007-03-23
EP1131073A1 (en) 2001-09-12
CA2348890C (en) 2009-05-12
EP1131073B1 (en) 2003-10-22
ZA200103925B (en) 2002-07-25
IL142757A0 (en) 2002-03-10
DE69912304T2 (de) 2004-07-22
IL142757A (en) 2007-07-04
DE69912304D1 (de) 2003-11-27
CA2348890A1 (en) 2000-06-02
NO328085B1 (no) 2009-11-30
CN1172673C (zh) 2004-10-27
AU1506600A (en) 2000-06-13
NO20012490D0 (no) 2001-05-21
WO2000030651A1 (en) 2000-06-02
CN1328462A (zh) 2001-12-26
PT1131073E (pt) 2004-03-31
HK1040182A1 (en) 2002-05-31
DK1131073T3 (da) 2004-02-02
ES2211197T3 (es) 2004-07-01
AU761092B2 (en) 2003-05-29

Similar Documents

Publication Publication Date Title
DE60138137D1 (de) Verfahren und zusammensetzungen zur behandlung von okularer neovaskularisierung und nervenverletzungen
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
DK0841949T3 (da) Anvendelse af saccharid-konjugater
DE69834658D1 (de) Verwendung von aminothiolverbindungen zur behandlung von nerven- und nieren-erkrankungen und der arzneimitteltoxizität
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
ECSP045098A (es) Procedimientos para tratar enfermedades neovasculares oculares
ATE323482T1 (de) Verwendung von p38 mapk inhibitoren in der behandlung von augenkrankheiten
BR9811012A (pt) "uso de um composto".
AP2002002596A0 (en) Piperazine and piperidine derivatives.
DE69305776D1 (de) Behandlung neurodegenerativer Krankheiten
AP2004003124A0 (en) Thiazole and oxazole derivatives which modulate PPAR activity
BR0210241A (pt) Piranoindazóis e seu uso no tratamento de glaucoma
DE69940951D1 (de) Nd wachstumshemmende mittel
NO990912D0 (no) Terapeutiske kombinasjoner av PAR-antagonister og RXR-antagonister og deres anvendelse
BR0109499A (pt) Tratamento melhorado de neovascularização
ID29970A (id) Metode untuk mengobati penyakit neovaskuler okuler
DE69613386D1 (de) Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen
WO2002039994A3 (en) Methods for the treatment and prevention of urinary stone disease
WO2000009098A3 (en) Method for treating ocular neovascular diseases
MXPA02011921A (es) Inhibidores de dipeptidasa acida n-acetilada-alfa-enlazada para el tratamiento de trastornos retinianos y glaucona.
EE200100026A (et) Oksasolidinoonid silmahaiguste raviks
SE9403160D0 (sv) Method and means for prevention and treatment of secondary cataract
DE69916013D1 (de) Vorderkammerimplantat zur behandlung des phaken auges
DE60215864D1 (de) Behandlung von okularen neovaskularen erkrankungen
BR0215752A (pt) Piranoindazóis e seu uso no tratamento de glaucoma